article thumbnail

Gender-affirming surgeries tripled in the U.S. between 2016-2019, study finds

STAT

nearly tripled between 2016 and 2019, according to new national estimates from a cohort study in JAMA Network Open. Over 48,000 people got some type of gender-affirming surgery between 2016-2020, with a slight decrease in the number of surgeries performed in 2020, likely because of the pandemic.

246
246
article thumbnail

STAT+: Two generic drugmakers pay $49 million to settle price-fixing charges

STAT

In 2016, a number of states filed what eventually became the first in a trio of lawsuits against many of the largest generic companies for allegedly coordinating efforts to fix and maintain prices for dozens of medications to treat a variety of ailments.

Diabetes 322
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: FDA’s new guidance on AI in drug development centers the risk introduced by the technology

STAT

In an interview with STAT in October, the FDA’s Tala Fakhouri, who co-leads the Center for Drug Evaluation and Research’s AI Council, said the agency has received over 500 drug submissions with AI components since 2016, with a large number in the areas of oncology, neurology, and gastroenterology. 

article thumbnail

Opinion: U.S. taxpayers should stop funding clinical trials of industry-owned drugs

STAT

  I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of only six contracts with NCI to conduct Phase 1 clinical trials from 1990-1995, and serving as co-chair of NCI’s Investigational Drug Steering Committee from 2005-2008.

article thumbnail

STAT+: Two of FDA’s top cancer regulators to depart, heightening worries about drug reviews

STAT

Kluetz, who joined the FDA as a medical reviewer in 2016, and Marc R. Both Paul G. Theoret, who joined as a medical reviewer in 2009, have told colleagues of plans to leave the FDA, multiple sources familiar with the matter told STAT.

341
341
article thumbnail

Opinion: Why isn’t there agreement on when women need to start getting mammograms?

STAT

The task force’s newest advice , which gives a “B” grade in favor of routine mammograms for women in their 40s, reverses its 2016 statement saying the test should be optional for such women. And that 2016 opinion conflicted with earlier task force recommendations.

332
332
article thumbnail

Long Covid is more prevalent among Americans with disabilities, new CDC data show

STAT

The data, gathered in 2022, is part of the agency’s Disability and Health Data System , which has annual state and national-level data stretching back to 2016. This comorbidity looms large for many disabled communities as another surge in Covid cases sweeps the country.

363
363